SH U04722
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SH U04722, covering 2014-12-31 to 2014-12-31. Get the full timeline:
Most recent: Clinical Trial Update: Dose Escalation Study of SH U04722 in Solid Tumors [Phase 1]